Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China

BACKGROUND: Amlodipine (AML) is the initial therapy most commonly prescribed for patients with hypertension in China. However, AML monotherapy is often less effective in achieving blood pressure (BP) control than other agents. OBJECTIVE: We performed a clinical study to evaluate efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Pingjin, Mei, Kezhi, Li, Hongwei, Dai, Qiuyan, Guo, Xingui, Zhang, Daifu, Jin, Zhimin, You, Hua, Ding, Hong, Lü, Ke, Zhou, Shuxian, Peng, Xiaoling, Xu, Hui, Yin, Pengfei, Yu, Licheng, Pi, Lin, Hua, Qi, Yang, Ming, Yu, Xiaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677643/
https://www.ncbi.nlm.nih.gov/pubmed/31388362
http://dx.doi.org/10.1016/j.curtheres.2015.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677643/
https://www.ncbi.nlm.nih.gov/pubmed/31388362
http://dx.doi.org/10.1016/j.curtheres.2015.09.001

Ejemplares similares